Safinamide is a drug indicated for the treatment of Parkinson's disease with multiple methods of action. Potential additional uses might be restless leg syndrome and epilepsy. Safinamide is a reversible and selective monoamine oxidase B inhibitor, reducing the degradation of dopamine, and a glutamate release inhibitor. It also inhibits dopamine reuptake. Safinamide also blocks sodium and calcium channels.

133865-89-1

C17H19FN2O2

302.34

EMD 1195686;FCE-26743;FCE 26743;FCE26743;EMD-1195686;沙芬酰胺;EMD1195686;Safinamide

DMSO:Soluble
Powder: -20°C for 3 years
In solvent: -80°C for 2 years